P22629 (SAV_STRAV) Streptomyces avidinii

Streptavidin UniProtKBInterProInteractive Modelling

183 aa; Sequence (Fasta)

Available Structures

276 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
scdSav(SARK)mv2 - Engineering Single-Chain Dimeric Streptavidin as Host for Artificial Metalloenzym… Heteromer
39-183
4IR;GOL;SO4;
Assess
cis-divalent streptavidin Heteromer
38-160
EDO;PG4;
Assess
Engineered streptavidin variant (ENAGY) in complex with the Twin-Strep-tag peptide Heteromer
38-160
Assess
Streptavidin complex with SBP-Tag Heteromer
39-159
Assess
T7-tagged full-length streptavidinhomo-4-mer38-183
GOL;SO4;
Assess
Streptavidin 8-aa-loop H127C mutein with reversible biotin bindinghomo-4-mer36-167
BTN;CL;
Assess
Circular Permuted Streptavidin A50/N49homo-4-mer42-172
BTN;GOL;SO4;EOH;
Assess
Circular Permuted Streptavidin N49/G48homo-4-mer42-172
BTN;SO4;
Assess
Streptavidin Mutant S27A with Biotin at 1.6A Resolutionhomo-4-mer37-163
BTN;
Assess
Wild-type core streptavidin at atomic resolutionhomo-4-mer38-163
MPD;MRD;
Assess
CRYSTAL STRUCTURE OF STREPTAVIDIN WITH PEPTIDE AFPDYLAEYHGGhomo-4-mer39-163
Assess
Crystal structure of the core streptavidin mutant V21 (Y22S/N23D/S27D/Y83S/R84K/E101D/R103K/E116N) …homo-4-mer37-161
ZOE;GOL;CD;P6G;
Assess
Spectroscopic and structural characterization of a genetically encoded direct sensor for protein-li…homo-4-mer37-161
PEG;
Assess
Streptavidin Mutant with Osteopontin Hexapeptide Insertion Including RGDhomo-4-mer40-163
MRD;
Assess
Streptavidin Mutant with Insertion of Fibronectin Hexapeptide, including RGDhomo-4-mer40-163
MRD;
Assess
Engineered streptavidin variant (VTAR) in complex with the Twin-Strep-tag peptidehomo-4-mer38-161
NH2;
Assess
Wild-type core streptavidin-biotin complex at atomic resolutionhomo-4-mer38-160
BTN;GOL;
Assess
Crystal structure of apo streptavidin at cryogenic temperaturehomo-4-mer38-160
MRD;MPD;
Assess
Streptavidin variants harbouring an artificial organocatalyst based cofactorhomo-4-mer38-160
HL9; 12×EDO;
Assess
Biotin complex of Y54F core streptavidinhomo-4-mer38-160
BTN;BSO;GOL;SO4;
Assess
Streptavidin mutant M112 (G26C/A46C)homo-4-mer36-158
BTN;
Assess
Crystal structure of wild-type core streptavidin in complex with D-biotin/biotin-D-sulfoxide at 1.3…homo-4-mer37-159
BTN; 10×GOL;BSO;SO4;
Assess
STREPTAVIDIN-2-IMINOBIOTIN-SULFATE COMPLEX, PH 3.50, SPACE GROUP I4122homo-4-mer37-159
SO4;IMI;
Assess
STREPTAVIDIN-GLYCOLURIL PH 2.58 I4122 COMPLEXhomo-4-mer37-159
ACT;SO4;GLL;
Assess
Artificial Metalloproteins with Dinuclear Iron Centershomo-4-mer38-160
Assess
Streptavidin variants harbouring an artificial organocatalyst based cofactorhomo-4-mer38-160
HL9;
Assess
STREPTAVIDIN-BIOTIN PH 2.0 I222 COMPLEXhomo-4-mer37-159
BTN;SO4;
Assess
STREPTAVIDIN-2-IMINOBIOTIN COMPLEX, PH 3.25, SPACE GROUP I222, CRYSTALLIZED FROM 4.3 M AMMONIUM SUL…homo-4-mer37-159
IMI;
Assess
STREPTAVIDIN-BIOTIN COMPLEX, PH 2.40, SPACE GROUP I222homo-4-mer37-159
CL;BTN;SO4;
Assess
APOSTREPTAVIDIN PH 2.0 I222 COMPLEXhomo-4-mer37-159
NA;CL;
Assess
STREPTAVIDIN-GLYCOLURIL COMPLEX, PH 2.50, SPACE GROUP I4122homo-4-mer37-159
GLL;FMT;
Assess
STREPTAVIDIN-GLYCOLURIL COMPLEX, PH 2.50, SPACE GROUP I222homo-4-mer37-159
GLL;FMT;
Assess
STREPTAVIDIN-2-IMINOBIOTIN-SULFATE COMPLEX, PH 2.50, SPACE GROUP I4122homo-4-mer37-159
SO4;IMI;
Assess
STREPTAVIDIN-CYCLO-[5-S-VALERAMIDE-HPQGPPC]K-NH2, PH 2.5, I222 COMPLEXhomo-4-mer37-159
LEA;
Assess
STREPTAVIDIN-CYCLO-[5-S-VALERAMIDE-HPQGPPC]K-NH2, PH 3.5, I222 COMPLEXhomo-4-mer37-159
LEA;
Assess
STREPTAVIDIN-CYCLO-[5-S-VALERAMIDE-HPQGPPC]K-NH2homo-4-mer37-159
LEA;
Assess
STREPTAVIDIN-BIOTIN COMPLEX, PH 2.00, SPACE GROUP I222homo-4-mer37-159
BTN;SO4;
Assess
APOSTREPTAVIDIN, PH 3.60, SPACE GROUP I222homo-4-mer37-159
10×SO4;
Assess
CRYSTAL STRUCTURE OF STREPTAVIDIN with cyclic peptide NQpWQhomo-4-mer38-160
Assess
STREPTAVIDIN-CYCLO-[5-S-VALERAMIDE-HPQGPPC]K-NH2, PH 1.5, I222 COMPLEXhomo-4-mer37-159
LEA;
Assess
APOSTREPTAVIDIN, PH 3.32, SPACE GROUP I222homo-4-mer37-159
NA;ACT;CL;
Assess
STREPTAVIDIN-BIOTIN COMPLEX, PH 1.90, SPACE GROUP I222homo-4-mer37-159
BTN;SO4;
Assess
STREPTAVIDIN-2-IMINOBIOTIN COMPLEX, PH 3.25, SPACE GROUP I222homo-4-mer37-159
IMI;
Assess
Streptavidin Mutant S27A at 1.5A Resolutionhomo-4-mer38-160
MRD;MPD;
Assess
STREPTAVIDIN-GLYCOLURIL COMPLEX, PH 2.50, SPACE GROUP I222homo-4-mer37-159
ACT;GLL;
Assess
STREPTAVIDIN-2-IMINOBIOTIN COMPLEX, PH 2.6, SPACE GROUP I222homo-4-mer37-159
IMI;
Assess
STREPTAVIDIN-BIOTIN PH 4.0 I222 COMPLEXhomo-4-mer37-159
BTN;SO4;
Assess
Streptavidin mutant M88 (N49C/A86C)homo-4-mer38-160
BTN;
Assess
APOSTREPTAVIDIN pH 3.0 I222 COMPLEXhomo-4-mer37-159
SO4;CL;IOD;NH4;
Assess
STREPTAVIDIN-2-IMINOBIOTIN COMPLEX, PH 4.0, SPACE GROUP I222homo-4-mer37-159
IMI;
Assess
STREPTAVIDIN-BIOTIN COMPLEX, PH 1.39, SPACE GROUP I222homo-4-mer37-159
BTN;
Assess
Crystal structure of the core streptavidin mutant V212 (Y22S/N23D/S27D/S45N/Y83S/R84K/E101D/R103K/E…homo-4-mer37-159
ZOF;P6G;
Assess
Crystal structure of apo streptavidin at ambient temperaturehomo-4-mer38-160
Assess
APOSTREPTAVIDIN, PH 5.6, TWO MOLECULES OF (SO4)2 BOUND AT THE BIOTIN BINDING SITEhomo-4-mer37-159
SO4;
Assess
STREPTAVIDIN, PH 5.6, BOUND TO PEPTIDE FCHPQNThomo-4-mer37-159
Assess
STREPTAVIDIN DIMERIZED BY DISULFIDE-BONDED PEPTIDE AC-CHPQNT-NH2 DIMERhomo-4-mer37-159
Assess
Streptavidin variants harbouring an artificial organocatalyst based cofactorhomo-4-mer38-160
HL9;EDO;GOL;
Assess
Structure of Streptactin, solved at wavelength 2.75 Ahomo-4-mer38-160
28×CL;GOL;
Assess
STREPTAVIDIN-2-IMINOBIOTIN COMPLEX, PH 2.0, SPACE GROUP I222homo-4-mer37-159
IMI;
Assess
STREPTAVIDIN-CYCLO-AC-[CHPQFC]-NH2, PH 11.8homo-4-mer37-159
Assess
STREPTAVIDIN-GLYCOLURIL COMPLEX, PH 2.58, SPACE GROUP I4122 PREPARED FROM AN APOSTREPTAVIDIN CRYSTALhomo-4-mer37-159
ACT;SO4;GLL;
Assess
STREPTAVIDIN-FSHPQNThomo-4-mer37-159
Assess
STREPTAVIDIN DIMERIZED BY DISULFIDE-BONDED PEPTIDE FCHPQNT-NH2 DIMERhomo-4-mer37-159
Assess
MINIPROTEIN MP-1 COMPLEX WITH STREPTAVIDINhomo-4-mer37-159
Assess
Spectroscopic and structural characterization of a genetically encoded direct sensor for protein-li…homo-4-mer38-160
BTN;
Assess
CORE STREPTAVIDIN-BNA COMPLEXhomo-4-mer37-159
BNI;
Assess
Epi-biotin complex with core streptavidinhomo-4-mer38-159
BTN;BTQ;GOL;
Assess
Crystal structure of the low-immunogenic core streptavidin mutant LISA-314 (Y22S/Y83S/R84K/E101D/R1…homo-4-mer37-158
BTN; 20×GOL;SO4;
Assess
Epi-biotin complex with core streptavidinhomo-4-mer38-159
BTN;BTQ;GOL;
Assess
CRYSTAL STRUCTURE OF STREPTAVIDIN WITH PEPTIDE D-amino acid containing peptide GyGlanvdessGhomo-4-mer38-159
IPA;
Assess
CRYSTAL STRUCTURE OF STREPTAVIDIN with D-amino acid containing peptide GGwhdeatwkpGhomo-4-mer39-160
Assess
CRYSTAL STRUCTURE OF STREPTAVIDIN WITH PEPTIDE RDPAPAWAHGGGhomo-4-mer39-160
NA;
Assess
Crystal structure of the core streptavidin mutant V21 (Y22S/N23D/S27D/Y83S/R84K/E101D/R103K/E116N) …homo-4-mer37-158
ZOF;GOL;
Assess
CRYSTAL STRUCTURE OF ALiS2-STREPTAVIDIN COMPLEXhomo-4-mer39-160
MT6;PE3;DMS;P6G;
Assess
APOSTREPTAVIDIN PH 3.12 I4122 STRUCTUREhomo-4-mer37-158
SO4;FMT;
Assess
CRYSTAL STRUCTURE OF STREPTAVIDIN WITH PEPTIDE GNSFDDWLASKGhomo-4-mer38-159
GOL;
Assess
Crystal structure of the core streptavidin mutant V21 (Y22S/N23D/S27D/Y83S/R84K/E101D/R103K/E116N) …homo-4-mer37-158
BTN;SO4;
Assess
Crystal structure of the core streptavidin mutant V212 (Y22S/N23D/S27D/S45N/Y83S/R84K/E101D/R103K/E…homo-4-mer37-158
ZOF;EDN;
Assess
Streptavidin variants harbouring an artificial organocatalyst based cofactorhomo-4-mer38-159
12×GOL;ACT;HL9;CL;
Assess
STREPTAVIDIN-BIOTIN PH 3.50 I4122 STRUCTUREhomo-4-mer37-158
BTN;
Assess
Streptavidin variants harbouring an artificial organocatalyst based cofactorhomo-4-mer39-160
HL9;
Assess
STREPTAVIDIN-BIOTIN PH 10.44 I222 COMPLEXhomo-4-mer37-158
BTN;
Assess
Co-crystallization of streptavidin-biotin complex with a lanthanide-ligand complex gives rise to a …homo-4-mer36-157
48×PDC;BTN; 20×TB;NA;
Assess
Wildtype Core-Streptavidin with Biotin at 1.4A.homo-4-mer38-159
BTN;
Assess
Streptavidin bound to peptide-like compound KPM-6homo-4-mer38-159
BZ4;HDO;
Assess
STREPTAVIDIN-2-IMINOBIOTIN PH 7.3 I222 COMPLEXhomo-4-mer37-158
IMI;
Assess
Streptavidin WT artificial metalloenzyme for carboaminationhomo-4-mer38-159
0OD;CL;SO4;
Assess
STREPTAVIDIN-BIOTIN PH 2.53 I4122 STRUCTUREhomo-4-mer37-158
BTN;
Assess
APOSTREPTAVIDIN PH 3.08 I222 COMPLEXhomo-4-mer37-158
NA;CL;FMT;NH4;
Assess
streptavidin mutant S112A with an iridium catalyst for CH activationhomo-4-mer38-159
NOF;
Assess
COMPLEX BETWEEN STREPTAVIDIN AND THE STREP-TAG II PEPTIDEhomo-4-mer38-159
Assess
COMPLEX BETWEEN STREPTAVIDIN AND THE STREP-TAG PEPTIDEhomo-4-mer38-159
Assess
an engineered streptavidin with improved affinity for the strep-tag II peptide : SAm1-StrepIIhomo-4-mer39-160
Assess
crystal structure of streptavidin mutant (M3) a combination of M1+M2homo-4-mer38-159
BNI;
Assess
Streptavidin Iron-Porphyrinhomo-4-mer38-159
JLL;IMD;FE;
Assess
Artificial imine reductase mutant S112A-N118P-K121A-S122Mhomo-4-mer38-159
6IR; 16×IR;ACT;SO4;
Assess
an engineered streptavidin with improved affinity for the strep-tag II peptide : SAm2-StrepIIhomo-4-mer39-160
Assess
Streptavidin variants harbouring an artificial organocatalyst based cofactorhomo-4-mer38-159
EDO;HL9;
Assess
Rapid crystallization of streptavidin using charged peptideshomo-4-mer39-160
GOL;
Assess
streptavidin mutant S112I with an iridium catalyst for CH activationhomo-4-mer38-159
NOF;
Assess
Crystal structure of a triple-mutant of streptavidin in complex with desthiobiotinhomo-4-mer38-159
DTB; 12×SO4;
Assess
Streptavidin with a bisbiothinilated Fe4S4 clusterhomo-4-mer38-159
NUI;
Assess
Streptavidin variants harbouring an artificial organocatalyst based cofactorhomo-4-mer38-159
HL9;EDO;
Assess
A Hyrdrogen Producing Hybrid Streptavidin-Diiron Catalysthomo-4-mer38-159
BN7;
Assess
Engineered streptavidin variant (YNAFM) in complex with the Strep-tag II peptidehomo-4-mer38-159
NH2;
Assess
Streptavidin variants harbouring an artificial organocatalyst based cofactorhomo-4-mer39-159
HL9;EDO;GOL;
Assess
WILDTYPE CORE-STREPTAVIDIN WITH a conjugated BIOTINYLATED PYRROLIDINEhomo-4-mer39-159
EYW;
Assess
STREPTAVIDIN MUTANT Y43Fhomo-4-mer39-159
MRD;MPD;
Assess
Wild-type streptavidin in complex with love-hate ligand 3 (LH3)homo-4-mer39-159
LH3;
Assess
Streptavidin in complex with Nanotaghomo-4-mer39-159
SO4;GOL;
Assess
Crystal structure of ALiS1-Streptavidin complexhomo-4-mer39-159
T21;
Assess
Artificial Metalloproteins with Dinuclear Iron Centershomo-4-mer38-158
KM3;ACT;
Assess
Artificial Iron Proteins: Modelling the Active Sites in Non-Heme Dioxygenaseshomo-4-mer38-158
QG7;
Assess
Coordination Chemistry within a Protein Host: Regulation of the Secondary Coordination Spherehomo-4-mer38-158
S18;CU;GOL;
Assess
APOSTREPTAVIDIN, PH 2.97, SPACE GROUP I4122homo-4-mer37-157
SO4;
Assess
Designed Artificial Cupredoxinshomo-4-mer38-158
SI9;
Assess
Artificial Iron Proteins: Modelling the Active Sites in Non-Heme Dioxygenaseshomo-4-mer38-158
QFY; 20×ACT;
Assess
Artificial Metalloproteins with Dinuclear Iron Centershomo-4-mer38-158
KM3;ACT;
Assess
Hydrophobic probe bound to Streptavidin - 1homo-4-mer38-158
N9O;
Assess
STREPTAVIDIN COMPLEXED WITH THE HEAD-TO-TAIL DISULFIDE-BONDED PEPTIDE DIMER OF CYCLO-AC-[CHPQGPPC]-…homo-4-mer37-157
Assess
APOSTREPTAVIDIN PH 2.00 I4122 STRUCTUREhomo-4-mer37-157
FMT;
Assess
Artificial Iron Proteins: Modelling the Active Sites in Non-Heme Dioxygenaseshomo-4-mer38-158
QG1;ACT;
Assess
STREPTAVIDIN COMPLEXED WITH THE HEAD-TO-TAIL DISULFIDE-BONDED PEPTIDE DIMER OF CYCLO-AC-[CHPQGPPC]-…homo-4-mer37-157
Assess
Traptavidin, biotin bound formhomo-4-mer39-159
BTN; 12×GOL;
Assess
Artificial Iron Proteins: Modelling the Active Sites in Non-Heme Dioxygenaseshomo-4-mer38-158
QFY; 12×ACT;
Assess
Peroxide Activation Regulated by Hydrogen Bonds within Artificial Cu Proteins - N49Ahomo-4-mer38-158
SI7;ACT;
Assess
STREPTAVIDIN-CYCLO-[5-S-VALERAMIDE-HPQGPPC]K-NH2, PH 3.5, I4122 COMPLEXhomo-4-mer37-157
LEA;
Assess
Artificial Metalloproteins with Dinuclear Iron Centershomo-4-mer38-158
KM3;ACT;
Assess
STREPTAVIDIN-CYCLO-AC-[CHPQFC]-NH2, PH 3.6homo-4-mer37-157
Assess
Peroxide Activation Regulated by Hydrogen Bonds within Artificial Cu Proteins - WThomo-4-mer38-158
SI8;ACT;SO4;CU;
Assess
Peroxide Activation Regulated by Hydrogen Bonds within Artificial Cu Proteins - S112Ahomo-4-mer38-158
SQ1;CU;GOL;SO4;
Assess
Engineered streptavidin variant (ENAGY) in complex with the Strep-tag II peptidehomo-4-mer39-159
Assess
streptavidin A86D mutant with love-hate ligand 4homo-4-mer39-159
LH4;PEG;CA;
Assess
Streptavidin with a fluorescent substratehomo-4-mer39-159
K9D;
Assess
Wild-type streptavidin in complex with biotin solved by native SAD with data collected at 6 keVhomo-4-mer39-159
BTN;
Assess
Artificial transfer hydrogenase with a Mn-5 cofactor and Streptavidin S112Y-K121M mutanthomo-4-mer38-158
X08;MN;BR;GOL;
Assess
trans-divalent streptavidinhomo-4-mer38-158
MPD;
Assess
Artificial Metalloproteins Containing a Co4O4 Active Site - 2xm-S112Y-ahomo-4-mer38-158
OL5;
Assess
STREPTAVIDIN-CYCLO-AC-[CHPQFC]-NH2, PH 4.2homo-4-mer37-157
Assess
Streptavidin with a Ni-cofactorhomo-4-mer39-159
WKF;NI;
Assess
Streptavidin S112YK121E artificial metalloenzyme for carboaminationhomo-4-mer38-158
0OD; 12×IR;
Assess
Peroxide Activation Regulated by Hydrogen Bonds within Artificial Cu Proteins - WT (low exposure)homo-4-mer38-158
SI0;ACT;SO4;
Assess
E. coli surface display of streptavidin for directed evolution of an allylic deallocasehomo-4-mer38-158
JCT;
Assess
STREPTAVIDIN COMPLEXED WITH CYCLO-AC-[CHPQGPPC]-NH2 MONOMER, PH 2.85homo-4-mer37-157
Assess
Crystal structure of streptavidin with one wild type subunit and three mutated subunits (N23A/S27D/…homo-4-mer39-159
PEG;
Assess
Artificial Metalloproteins with Dinuclear Iron Centershomo-4-mer38-158
KM3;ACT;
Assess
STRUCTURE-BASED DESIGN OF SYNTHETIC AZOBENZENE LIGANDS FOR STREPTAVIDINhomo-4-mer37-157
DMB;
Assess
T7-tagged full-length streptavidin complexed with ruthenium ligandhomo-4-mer38-158
KYS;
Assess
STREPTAVIDIN-CYCLO-[5-S-VALERAMIDE-HPQGPPC]K-NH2, PH 2.5, I4122 COMPLEXhomo-4-mer37-157
LEA;
Assess
Designed Artificial Cupredoxinshomo-4-mer38-158
CU6;
Assess
Designed Artificial Cupredoxinshomo-4-mer38-158
SI4;GOL;
Assess
Expanding Nature's Catalytic Repertoire -Directed Evolution of an Artificial Metalloenzyme for In V…homo-4-mer38-158
9RU;SO4;
Assess
AN ENGINEERED STREPTAVIDIN WITH IMPROVED AFFINITY FOR THE STREP-TAG II PEPTIDE : apo-SAM2homo-4-mer39-159
Assess
Artificial Metalloproteins with Dinuclear Iron Centershomo-4-mer38-158
KM3;CYN;ACT;
Assess
Artificial Metalloproteins with Dinuclear Iron Centershomo-4-mer38-158
KM3;AZI;ACT;
Assess
Photo-Driven Hydrogen Evolution by an Artificial Hydrogenase Utilizing the Biotin-Streptavidin Tech…homo-4-mer38-158
9CO;
Assess
Engineered streptavidin variant (H--WY) in complex with the Strep-tag II peptidehomo-4-mer39-159
12×PGE;TRS;
Assess
Designed Artificial Cupredoxins - WThomo-4-mer38-158
CU6;GOL;ACT;
Assess
Streptavidin variants harbouring an artificial organocatalyst based cofactorhomo-4-mer39-159
HL9;
Assess
STREPTAVIDIN COMPLEXED WITH CYCLO-AC-[CHPQGPPC]-NH2 MONOMER, PH 2.5homo-4-mer37-157
Assess
Streptavidin-S112Y-K121E Complexed with Palladium-Containing Biotin Ligandhomo-4-mer38-158
SVP;CL;
Assess
MINIPROTEIN MP-2 COMPLEX WITH STREPTAVIDINhomo-4-mer37-157
Assess
STRUCTURE-BASED DESIGN OF SYNTHETIC AZOBENZENE LIGANDS FOR STREPTAVIDINhomo-4-mer37-157
NAB;
Assess
Artificial Metalloproteins with Dinuclear Iron Centershomo-4-mer38-158
KM3;AZI;ACT;
Assess
Sav-SOD: Chimeric Streptavidin-cSOD as Host for Artificial Metalloenzymeshomo-4-mer39-159
UFW;
Assess
Hydrophobic probe bound to Streptavidin - 2homo-4-mer38-158
N9O;
Assess
STREPTAVIDIN-CYCLO-AC-[CHPQFC]-NH2, PH 4.8homo-4-mer37-157
Assess
Artificial Iron Proteins: Modelling the Active Sites in Non-Heme Dioxygenaseshomo-4-mer38-158
QG4; 12×ACT;
Assess
Streptavidin-K121Hhomo-4-mer38-158
0OD;RH;
Assess
STREPTAVIDIN-CYCLO-AC-[CHPQFC]-NH2, PH 2.0homo-4-mer37-157
Assess
STREPTAVIDIN-CYCLO-AC-[CHPQFC]-NH2, PH 3.0homo-4-mer37-157
Assess
Artificial Transfer Hydrogenases for the Enantioselective Reduction of Cyclic Imineshomo-4-mer38-158
4IR;IR3;
Assess
Artificial Metalloproteins with Dinuclear Iron Centershomo-4-mer38-158
KM3;CYN;
Assess
An engineered streptavidin with improved affinity for the strep-tag II peptide: apo-SAM1homo-4-mer39-159
Assess
Artificial imine reductase mutant S112A-N118P-K121A-S122Mhomo-4-mer38-158
4IR; 12×IR;
Assess
Chaperoned ruthenium metallodrugs that recognize telomeric DNAhomo-4-mer38-158
KYT;SO4;GOL;
Assess
STREPTAVIDIN COMPLEXED WITH CYCLO-AC-[CHPQGPPC]-NH2 MONOMER, PH 3.67homo-4-mer37-157
Assess
CRYSTAL STRUCTURE AND LIGAND BINDING STUDIES OF A SCREENED PEPTIDE COMPLEXED WITH STREPTAVIDINhomo-4-mer37-157
Assess
STREPTAVIDIN, PH 5.0, BOUND TO CYCLIC PEPTIDE AC-CHPQGPPC-NH2homo-4-mer37-157
Assess
Engineered streptavidin variant (ACGR) in complex with the Strep-tag II peptidehomo-4-mer39-159
Assess
streptavidin mutant S112I K121R with an iridium catalyst for CH activationhomo-4-mer38-158
NOF;SO4;
Assess
streptavidin-norbiotin complexhomo-4-mer39-159
SNR;
Assess
Streptavidin-S112Hhomo-4-mer38-158
0OD; 16×CL;RH;
Assess
STREPTAVIDIN, PH 7.5, BOUND TO CYCLIC DISULFIDE-BONDED PEPTIDE LIGAND AC-CHPQFC-NH2homo-4-mer37-157
Assess
Structural-, Kinetic- and Docking Studies of Artificial Imine Reductases Based on the Biotin-Strept…homo-4-mer38-158
5IR;IR;
Assess
STRUCTURAL ORIGINS OF HIGH-AFFINITY BIOTIN BINDING TO STREPTAVIDINhomo-4-mer37-157
BTN;
Assess
Crystal structure of streptavidin mutant L124R (M1) complexed with biotinyl p-nitroanilide (BNI)homo-4-mer39-159
BNI;
Assess
Full Matrix Error Analysis of Streptavidinhomo-4-mer40-159
BTN;GOL;MPD;
Assess
Wild-type streptavidin in complex with love-hate ligand 1 (LH1)homo-4-mer40-159
LUV;
Assess
Crystal structure of streptavidin mutant (M2) where the L3,4 loop was replace by that of avidinhomo-4-mer40-159
BNI;
Assess
Crystal structure of ALiS3-Streptavidin complexhomo-4-mer40-159
6F3;
Assess
WILDTYPE CORE-STREPTAVIDIN WITH a conjugated BIOTINYLATED PYRROLIDINE IIhomo-4-mer40-159
UJE;
Assess
Core-streptavidin mutant F130L in complex with biotinhomo-4-mer40-159
BTN; 11×GOL;
Assess
Y54F mutant of core streptavidinhomo-4-mer40-159
CL;EDO;
Assess
Structure of D128N streptavidinhomo-4-mer40-159
BTN;
Assess
Artificial Metalloproteins Containing a Co4O4 Active Site - 2xm-S112Y-bhomo-4-mer38-157
OL3;
Assess
Artificial Metalloproteins Containing a Co4O4 Active Site - 2xm-S112Y-bhomo-4-mer38-157
BTN;
Assess
Traptavidin, apo-formhomo-4-mer40-159
GOL;
Assess
Coordination Chemistry within a Protein Host: Regulation of the Secondary Coordination Spherehomo-4-mer38-157
S31;CU;
Assess
Artificial metalloproteins containing a Co4O4 active site - 2xm-Savhomo-4-mer38-157
OLS;
Assess
streptavidin with an iridium catalyst for CH activationhomo-4-mer39-158
NOF;SO4;
Assess
Crystal structure of ALiS4-Streptavidin complexhomo-4-mer40-159
SO3;6FX;
Assess
S45A MUTANT OF STREPTAVIDIN IN COMPLEX WITH BIOTINhomo-4-mer40-159
BTN;
Assess
Genetic Engineering of an Artificial Metalloenzyme for Transfer Hydrogenation of a Self-Immolative …homo-4-mer39-158
4IR; 16×IR3;
Assess
CRYSTAL STRUCTURE OF STREPTAVIDIN D-amino acid containing peptide Gdlwqheatwkkqhomo-4-mer39-158
Assess
trans-divalent streptavidin with love-hate ligand 4homo-4-mer40-159
LH4;
Assess
Coordination Chemistry within a Protein Host: Regulation of the Secondary Coordination Spherehomo-4-mer38-157
S32;CU;GOL;
Assess
Structure of Savm-W120K, streptavidin mutanthomo-4-mer40-159
BTN;
Assess
Artificial Metalloproteins Containing a Co4O4 Active Site - 2xm-S112Fhomo-4-mer38-157
OL4;
Assess
Streptavidin Mutant Y43A at 1.70A Resolutionhomo-4-mer40-159
MRD;
Assess
CORE-STREPTAVIDIN MUTANT W79F AT PH 4.5homo-4-mer40-159
Assess
STREPTAVIDIN MUTANT Y43A WITH IMINOBIOTIN AT 1.8A RESOLUTIONhomo-4-mer40-159
IMI;
Assess
Chimeric Streptavidin With A Dimerization Domain For Artificial Transfer Hydrogenationhomo-4-mer39-158
4IR;
Assess
APO-CORE-STREPTAVIDIN AT PH 7.5homo-4-mer40-159
Assess
Artificial transfer hydrogenase with a Mn-12 cofactor and Streptavidin S112Y-K121M mutanthomo-4-mer39-158
WZQ;MN;BR;CL;
Assess
APO-CORE-STREPTAVIDIN AT PH 4.5homo-4-mer40-159
Assess
SFX structure of corestreptavidin-selenobiotin complexhomo-4-mer40-159
BYY;
Assess
CORE-STREPTAVIDIN MUTANT W120A AT PH 7.5homo-4-mer40-159
Assess
CORE-STREPTAVIDIN MUTANT W120F AT PH 7.5homo-4-mer40-159
Assess
Streptavidin mutant S112R with a biotC4-1 cofactor - an artificial iron hydroxylasehomo-4-mer39-158
O6T;
Assess
STREPTAVIDIN MUTANT N23E AT 1.96Ahomo-4-mer40-159
Assess
Streptavidin WT Co-TAML artificial metalloenzymehomo-4-mer39-158
VJL;SO4;
Assess
Streptavidin S112Y Co-TAML artificial metalloenzymehomo-4-mer39-158
VJL;NA;SO4;
Assess
CORE-STREPTAVIDIN MUTANT W108F IN COMPLEX WITH BIOTIN AT PH 7.0homo-4-mer40-159
BTN;
Assess
1.70 A cryo-EM structure of streptavidinhomo-4-mer39-158
BTN;
Assess
1.77 A cryo-EM structure of Streptavidin using first 40 frames (corresponding to about 40 e/A^2 tot…homo-4-mer39-158
BTN;
Assess
Streptavidin wildtype with a biotC5-1 cofactor - an artificial iron hydroxylasehomo-4-mer39-157
O7Q;GOL;
Assess
dithiol-ligand bound to streptavidinhomo-4-mer39-157
PEG;K9R;
Assess
Streptavidin mutant S112R with a biotC5-1 cofactor - an artificial iron hydroxylasehomo-4-mer39-157
O7Q;GOL;
Assess
Streptavidin wildtype with a biotC4-1 cofactor - an artificial iron hydroxylasehomo-4-mer39-157
O6T;GOL;
Assess
Crystal Structure of Streptavidin Double Mutant S45A/D128A with Biotin: Cooperative Hydrogen-Bond I…homo-4-mer40-158
BTN;
Assess
MINIPROTEIN MP-2 (M9A) COMPLEX WITH STREPTAVIDINhomo-4-mer40-158
Assess
CRYSTALLOGRAPHIC AND THERMODYNAMIC COMPARISON OF NATURAL AND SYNTHETIC LIGANDS BOUND TO STREPTAVIDINhomo-4-mer39-157
HAB;
Assess
CORE-STREPTAVIDIN MUTANT W108F AT PH 7.0homo-4-mer40-158
Assess
MINIPROTEIN MP-2 (V10A) COMPLEX WITH STREPTAVIDINhomo-4-mer40-158
Assess
STRUCTURE-BASED DESIGN OF SYNTHETIC AZOBENZENE LIGANDS FOR STREPTAVIDINhomo-4-mer39-157
MHB;
Assess
Streptavidin mutant S112R_K121E with a biotC5-1 cofactor - an artificial iron hydroxylasehomo-4-mer39-157
O7Q;SO4;
Assess
streptavidin-BCAP complexhomo-4-mer40-158
BH7;
Assess
Streptavidin mutant S112R,K121E with a biotC4-1 cofactor - an artificial iron hydroxylasehomo-4-mer39-157
O6T;
Assess
STRUCTURE-BASED DESIGN OF SYNTHETIC AZOBENZENE LIGANDS FOR STREPTAVIDINhomo-4-mer39-157
MTB;
Assess
Structure of streptavidin mutant (S112Y-K121E) complexed with biotin-cyclopentadienyl-rhodium (III)…homo-4-mer39-157
RH3;JSU; 18×GOL;CL; 10×SO4;
Assess
STRUCTURE-BASED DESIGN OF SYNTHETIC AZOBENZENE LIGANDS FOR STREPTAVIDINhomo-4-mer39-157
MOB;
Assess
streptavidin-homobiotin complexhomo-4-mer40-158
SHM;
Assess
trans-divalent streptavidin bound to biotin-4-fluoresceinhomo-4-mer39-157
MPD;B4F;
Assess
Biotin-bound streptavidinhomo-4-mer40-158
BTN;
Assess
Cryo-EM structure of streptavidinhomo-4-mer40-158
Assess
Cryo-EM structure of streptavidinhomo-4-mer40-158
Assess
Apo-state streptavidinhomo-4-mer40-158
Assess
1.93 A cryo-EM structure of streptavidinhomo-4-mer40-158
Assess
Streptavidin Mutant N23A with biotin at 1.89Ahomo-4-mer40-157
BTN;
Assess
CORE-STREPTAVIDIN MUTANT W120A IN COMPLEX WITH BIOTIN AT PH 7.5homo-4-mer40-157
BTN;
Assess
APO-CORE-STREPTAVIDIN IN COMPLEX WITH BIOTIN (TWO UNOCCUPIED BINDING SITES) AT PH 4.5homo-4-mer40-157
BTN;
Assess
CORE-STREPTAVIDIN MUTANT D128A IN COMPLEX WITH BIOTIN AT PH 4.5homo-4-mer40-157
BTN;
Assess
CORE-STREPTAVIDIN MUTANT W79F AT PH 4.5homo-4-mer40-157
Assess
APO-CORE-STREPTAVIDIN IN COMPLEX WITH BIOTIN AT PH 4.5homo-4-mer40-157
BTN;
Assess
STREPTAVIDIN MUTANT N23A AT 2.18Ahomo-4-mer40-157
Assess
APO-CORE-STREPTAVIDIN AT PH 4.5homo-4-mer40-156
Assess
Streptavidin Mutant Y43F with Biotin at 1.81A Resolutionhomo-4-mer40-156
BTN;
Assess
CORE-STREPTAVIDIN MUTANT D128A AT PH 4.5homo-4-mer40-156
Assess
CORE-STREPTAVIDIN MUTANT W120F IN COMPLEX WITH BIOTIN AT PH 7.5homo-4-mer40-156
BTN;BTQ;
Assess
CORE-STREPTAVIDIN MUTANT W79F IN COMPLEX WITH BIOTIN AT PH 4.5homo-4-mer40-156
BTN;BTQ;
Assess
CIRCULAR PERMUTED STREPTAVIDIN E51/A46 IN COMPLEX WITH BIOTINhomo-4-mer75-178
BTN;
Assess
CIRCULAR PERMUTED STREPTAVIDIN E51/A46homo-4-mer76-172
Assess
scdSav(SASK) - Engineering Single-Chain Dimeric Streptavidin as Host for Artificial Metalloenzymeshomo-2-mer39-183
4IR;GOL;
Assess
Crystal structure of ligand-free R7-2 streptavidinhomo-2-mer37-159
GOL;
Assess
CRYSTAL STRUCTURE OF STREPTAVIDIN WITH PEPTIDE EWVHPQFEQKAKhomo-2-mer38-159
Assess
Spectroscopic and structural characterization of a genetically encoded direct sensor for protein-li…homo-2-mer38-159
CL;
Assess
Spectroscopic and structural characterization of a genetically encoded direct sensor for protein-li…homo-2-mer38-159
BTN;
Assess
Spectroscopic and structural characterization of a genetically encoded direct sensor for protein-li…homo-2-mer40-160
GOL;CL;
Assess
Crystal structure of R7-2 streptavidin complexed with biotinmonomer37-159
BTN;NI;SO4;GOL;
Assess
Crystal structure of R7-2 streptavidin complexed with PEGmonomer37-159
GOL;1PE;
Assess
Crystal structure of R4-6 streptavidinmonomer37-159
GOL;
Assess
Crystal structure of R4-6 streptavidinmonomer37-159
1PE;GOL;
Assess
Crystal structure of the refolded R7-2 streptavidinmonomer37-158
1PE;
Assess
Crystal structure of R7-2 streptavidin complexed with desthiobiotinmonomer37-158
DTB;NI;NA;GOL;
Assess
Crystal structure of R7-2 streptavidin complexed with biotin/PEGmonomer37-158
1PE;BTN;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5n99.2.Ahomo-4-mer0.7738-159
ASN;100.00
Assess